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ABSTRACT 
At present, there is a lot of research about the pyrazoline heterocyclic compound, its ring structure is being changed and new derivatives are being 
made, many of which have antimicrobial activity over the derivatives. Pyrazoline is the five-member heterocyclic ring which have two N atoms in 
nearby position and contains two endocyclic double bonds. Noteworthy consideration has been concentrated on pyrazolines and pyrazoline 
derivative due to their important pharmacological action. Some replaced pyrazolines have been stated near retain particular important 
pharmacological actions as antimicrobial, antifungal, antineoplastic, antidepressant, insecticidal, anticonvulsant, anti-inflammatory, antibacterial 
and antitumor properties.  
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INTRODUCTION 
Microbial Infections (fungal and bacterial) have been informed to 
rise affected globally in present days and main causes are toward 
the block resistance. Both hospitalized and ambulatory patients are 
very needful of antimicrobials widespread. It is described that 24% 
to 40.8% of hospitalized persons accept them [1]. Destruction of 
resistance owing to several causes such as distortion, operations, 
immunosuppressive treatments, old age, HIV infection, is a 
reasonable sources that seats patients at great risk for transmittable 
contagious contaminations. This condition is exacerbated through 
growing rate of microbial conflict to the general antibiotics existing 
nowadays [2]. Antimicrobial altercation is a main anxiety, the threat 
to the community health in addition permits improvement and 
development of new and active antibiotics to challenge drug quarrel. 
To reveal these matters, there is a essential to develop new 
insignificant, harmless and effective drugs with a wide range of 
antimicrobial action [3]. There are several heterocyclic ring 
compounds having nitrogen atom such as pyrazole, pyrrolones, 
pyridazinones, pyrazolines have been considered generally used for 
the improvement of essential antimicrobial action. The powerful 
new drugs must been displayed to save lives when used to give some 
severe infections and to reduce the trouble of illness when used 
prophylactically in certain clinical situation. For the synthesis of new 
antibiotics, researcher effort lots on chemical compounds and 
pyrazoline derivatives are valuable as antimicrobial agents. 
Pyrazolines are enormously valuable nitrogen-containing 
heterocyclic compounds that occur in a diversity of chemical and 
biological agents and improve their activities. N–N bond of the 
pyrazoline ring is restrained to be the important cause in their 
biological activities [4]. Pyrazoline can be defined as dihydro 
pyrazole having only one endocyclic double bond. On the basis of the 
position of the double bond three types of pyrazoline are possible: 
(i) 1-pyrazoline (ii) 2-pyrazoline and (iii) 1, 3-pyrazoline, 2-
pyrazoline is most attractive and important among all type of 
pyrazolines for frequent studies. 
 
 
Fig. 1: Types of pyrazoline 
Actually, pyrazolines are the reduced forms of pyrazoles, while 
pyrazolidine is a completely reduced form of pyrazole. 
 
 
Fig. 2: Hydrogenation of pyrazole to pyrazoline then 
pyrazolidine 
 
Pyrazoline derivatives have been found in natural products in the 
form of vitamins, alkaloids, and pigments. 
Pyrazoline end products were stated to retain a number of evident 
pharmacological activities, antimoebic, antimicrobial, antibacterial, 
antidepressant, antitubercular, antifungal, antiviral, anticancer, 
anticonvulsant. Some of the modern drugs of the pyrazoline nucleus 
include Phenazone, Metamizole, Aminopyrine, Phenylbutazone, 
Sulfinpyrazone, Oxyphenbutazone and Celecoxib. The literature 
search was steered using accessible databases, including 
ScienceDirect, PubMed, Scopus and Google Scholar. The 
dissertations, thesis, books and technical reports were also combed. 
The objective of this review is to provide all the literature of 
approximately fifteen years.  
Antimicrobial activity of pyrazoline derivatives 
Chimenti et al. (2005) prepared N-substituted 3, 5-diphenyl 
pyrazoline derivatives and then screened for antibacterial activity. 
All pyrazoline derivatives displayed minute activity or no activity 
against different bacteria and fungus. The similar derivatives 
displayed a substantial activity against H. pylori strains. Between the 
synthesized derivatives, which containing the N-acetyl group and 
methoxy group at position 4 on the phenyl ring exhibited the 
greatest potential against metronidazole resistant H. pylori strains at 
the 1–4 μg/ml [5]. 
Shivarama et al. (2005) reflux aryl furfurals with different 
acetophenones then condensate Aryl furyl propenones. Cyclo-
condensation provided 1H-pyrazoline derivatives and N-
phenylpyrazoline derivatives, respectively, when arylfuryl 
propenones react with hydrazine hydrate and phenylhydrazine. We 
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Fig. 3: Some of the modern drugs having pyrazoline nucleus 
 
 
Fig. 4: N-substituted 3, 5-diphenyl pyrazoline derivatives 
 
Ozdemir et al. (2007) synthesized 1-(4-aryl-2-thiazolyl)-3-(2-
thienyl)-5-aryl-2-pyrazoline derivatives from phenacyl bromides in 
ethanol. All manufactured derivatives evaluated against E. coli, S. 
typhimurium, S. aureus, S. faecalis, B. cereus, A. hydrophila, C. 
albicans, C. glabrata for antimicrobial activity [7]. 
 
 
Fig. 5: Substituted 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-
pyrazoline 
Kaplanciki et al. (2007) synthesized the substituted pyrazoline 
derivatives. For this, when phenacyl bromides react with different 3-
(2-thienyl)-5-aryl-1-thiocarbamoyl-2-pyrazolines in ethanol results 
1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives. 
The antimicrobial activity of synthesized compound was evaluated 
in contrast to S. typhimurium, E. coli, B. cereus, A. hydrophila, L. 
monocytogenes, S. aureus, C. albicans, and C. glabrata [8]. 
Kaplanciki et al. (2007) reported the newly prepared 1-(4-aryl-2-
thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives by substituted 
3-(2-thienyl)-5-aryl-1-thiocarbamoyl-2-pyrazolines. The antimicrobial 
activity of synthesized pyrazoline derivatives was screened against 
bacterial strains E. coli, S. aureus, S. typhimurium, B. cereus, L. 
monocytogenes, A. hydrophila, C. albicans, and C. glabrata [9]. 
Shaharyar et al. (2007) synthesized the pyrazoline derivatives by 4-
hydroxy-3-methylacetophenone condensed with different aromatic 
aldehydes in methanolic KOH results chalcones. These chalcones react 
with the hydrazine hydrate in ethanol to results pyrazoline 
derivatives. All synthesized derivatives were evaluated against 
Mycobacterium tuberculosis H37Rv for their anti-tubercular activity. 
The novel heterocyclic compound displayed favorable anti-tubercular 
activity against Mycobacterium tuberculosis drug-sensitive and drug-
resistant strains of Mycobacterium tuberculosis [10]. 
 
 
Fig. 6: 4-hydroxy phenyl pyrazoline derivatives 
 
Munawar et al. (2008) explained the quinolinyl chalcones react with 
phenyl hydrazine to obtain a series of 2-pyrazoline derivatives 
under both conventional and microwave-induced method. All 
synthesized compounds were evaluated for antimicrobial activity 
against bacteria S. aureus, S. typhii, E. coli, and Shigella dysentery. All 
synthesized derivatives have displayed antimicrobial activity. The 
compounds which containing a chloro group as a substituent has 
been more potent antimicrobial activity [11]. 
 
 
Fig. 7: Quinolinyl 2-pyrazoline derivatives 
 
Kiniet al. (2008) reacting isoniazid with substituted diaryl chalcones 
in N, N-DMF to synthesize the 1, 3, 5-trisubstituted-2-pyrazoline 
derivatives. All the synthesized derivatives screened for in vitro 
antimicrobial activity against E. coli, P. aeruginosa, B. subtilis, S. 
aureus and A. niger at different concentrations, compounds show 
significant antimicrobial activity [12]. 
 
 
Fig. 8: 1, 3, 5-trisubstituted-2-pyrazoline 
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Kini et al. (2008) reported when the isoniazid reflux with different 
substituted diaryl chalcones in N,N-dimethyl formamide at 120-140 
° results 1,3,5-trisubstituted-2-pyrazolines. For antimicrobial 
activity, the synthesized compounds were screened against B. 
subtilis, S. aureus, P. aeruginosa, A. niger and E. coli. Also the 
quinolinyl chalcones react with phenyl hydrazine to obtain series of 
2-pyrazolines under both conventional and microwave-induced 
warming method. All synthesized compounds were evaluated for 
antimicrobial activity against S. aureus, S. typhii, E. coli, and Shigella 
dysentery. All synthesized derivatives have displayed antimicrobial 
activity. The compounds containing chloro group as a substituent 
have been more potent antimicrobial activity [13].  
Ramesh et al. (2009) prepared the chalcones of 2-acetyl thiophene 
reflux with phenylhydrazine hydrochloride in alkaline alcohol 
outcomes new pyrazoline derivatives. Some of these derivatives 
exhibited moderate to considerable antimicrobial activity. The 
results are showing that the compounds 1 and 2 showed significant 
antibacterial activity at conc. of 0.05-0.1 ml concentration levels as 
compared through standard drug sparfloxacin. The other 
compounds 3, 4 and 5 displayed adequate activity [14]. 
 
 
Fig. 9: Thiophene pyrazoline derivatives 
 
Manna et al. (2009) reported a series of 2-[1-(5,8-
Dihydroquinoxalino[2,3-b]indoloacetyl)-3-(1-benzofuran-2-yl)-4,5-
dihydro-1H-pyraz-ol-5-yl] phenyl derivatives which is synthesized 
by reacting the 2-(5,8-dihydro quinoxalino[2,3-b]indol-5-yl) 
acetohydrazide with (2E)-1-(1-benzofuran-2-yl)-4-phenylbut-2-en-
1-ones derivatives by microwave-assisted method. Some 
compounds were show decent antibacterial activity against S. 
aureus, P. aeruginosa and E. coli, compared with standard drugs 
sparfloxacin and norfloxacin at the conc. of 10 μg/ml [15].  
 
 




Chawla et al. (2010) synthesized substituted [3-(4-phenyl)-5-
phenyl-4, 5-dihydropyrazol-1-yl](pyridine-4-yl)methanone and 3-
substituted phenyl-5-substituted phenyl-4,5-dihydro-pyrazole-1-
carbothioamides by microwave techniques. All the derivatives were 
evaluated for antibacterial activity against B. subtilis, E. coli, P. 
aeruginosa and S. aureus and antifungal activity beside C. albicans, A. 
niger. The derivatives showed adequate antibacterial and 
respectable antifungal actions [16]. 
 
Fig. 11: (a) substituted [3-(4-phenyl)-5-phenyl-4,5-dihydropyrazol-
1-yl](pyridine-4-yl)methanones, (b) 3-substituted phenyl-5-
substituted phenyl-4,5-dihydro-pyrazole-1-carbothioamides  
 
Sivakumar et al. (2010) manufactured novel 1, 3, 
5-triphenyl-2-pyrazoline derivatives and two-fold dilution method 
using resazurin (indicator dye) is used for screening of antibacterial 
activity against S. aureus, S. typhi, B. subtilis, E. aerogenes, P. 
aeruginosa and Proteus vulgaris by SAR study concluded that 1,3,5-
triphenyl-2-pyrazoline derivatives. Chlorine replacement in the ring A, 
is the positive discrimination for antibacterial activity. 




Fig. 12: Novel 1, 3, 5-triphenyl-2-pyrazoline derivatives 
 
Venkataraman et al. (2010) synthesized some new pyrazoline 
derivatives from Chalcones. Which may be synthesized by different 
acetophenones react with different benzaldehydes to give chalcone, 
which on condensed with hydrazine hydrate in ethanol to acquire 
pyrazoline derivatives. All derivatives were tested for in vitro 
antibacterial and anti-inflammatory activities. All synthesized 
derivatives were confirmed activity against S. aureus, B. subtilis, E. 
coli, P. aureginosa. Some of the new derivatives exhibited promising 
anti-inflammatory activities [18]. 
 
 
Fig. 13: 3, 5 diphenyl pyrazoline 
 
Sakthinathan et al. (2012), reported that when 2-naphthyl chalcones 
in the presence of phenylhydrazine hydrochloride and sodium 
acetate by the cyclization reaction results 2-naphthyl pyrazoline 
derivatives. 2-naphthyl pyrazoline derivatives subjected for 
antimicrobial activity [19]. 
 
 
Fig. 14: 2-naphthyl pyrazoline derivatives 
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Shah et al. (2012) synthesized 4-(4-hydroxyphenyl)-3-chloro-1-{4-[5-
(substituted phenyl)-1-phenyl-4,5-dihydro-pyrazol-3-yl]phenyl} 
azetidin-2-one by 3-chloro-1-{4-[3-(substituted-phenyl)prop-2-enoyl] 
phenyl}-4-(4-hydroxyphenyl) azetidin-2-one (0.01M) and phenyl-
hydrazine (0.01 M) in presence of glacial acetic acid. All the synthesized 
derivatives were screened for antimicrobial activity through broth 
dilution method. The compound containing chloro substitution in the 
phenyl ring has shown respectable antibacterial activity [20]. 
 
 
Fig. 15: 4-(4-hydroxyphenyl)-3-chloro-1-{4-[5-(substituted 
phenyl)-1-phenyl-4,5-dihydro-pyrazol-3-yl]phenyl} azetidin-2-one 
 
Rani et al.(2012) prepared alkoxy a series of N-substituted cyclized 
pyrazoline equivalents [5-(furan-2-yl)-3-[2-(alkoxy) phenyl]-4, 5-
dihydro-1H-pyrazole-1-carbothioamide by cyclization of [1-[2-
(alkoxy) phenyl]-5-(furan-2-yl)-prop-2-en-1-one] chalcone with 
thiosemicarbazide in the presence of alkaline ethanol. By the disc 
diffusion method, in vitro antibacterial activity of newly prepared 
derivatives were screened and the minimum inhibitory 
concentration (MIC) was calculated against microorganism such as 
A. hydrophila, Y. enterocolitica, L. monocytogenes, and S. aureus. 
Between all the compounds, alkoxy [5-(furan-2-yl)-2-
(benzyloxy)phenyl]-4,5-dihydro-1H-pyrazole-1-carbothioamide and 
5-(furan-2-yl)-1-[2-(naphthalen-2-ylmethoxy) phenyl]-4,5-dihydro-
1H-pyrazole-1-carbothioamide exhibited the greatest favorable 




Fig. 16: N-substituted cyclized pyrazoline 
 
Dipankar et al. (2012) synthesized twelve 2-pyrazoline derivatives 
and evaluated the antimicrobial activity against A. niger and S. 
aureus. For this, 2 types of acetophenone reacted with 3 types of 
substituted benzimidazole derivatives to acquire 6 chalcone 
derivatives, which undergo condensation and cyclisation with 
isoniazid and 1-(2-napthyloxy acetate) hydrazine to acquire the 2-
pyrazoline derivatives. The synthesized derivatives were established 
to have good antimicrobial activity at the conc. of 20-70 μg/ml [22].  
S Y Hassan (2013) has reported a series of new 2-pyrazoline 
derivative carrying benzene sulfonamide moieties were produced by 
reaction of suitable chalcones with 4-hydrazinyl benzene 
sulfonamide HCl. Besides the reaction of chalcones with the 
hydrazine derivative produces pyrazole compounds. All the 
synthesized compounds have been categorized by physical and 
spectral fig. Antimicrobial activity of synthesized compounds were 
tested against S. aureus, P. aeruginosa, E. coli and antifungal activity 
in contrast to C. albicans must been considered by the nutrient agar 
and saboraud dextrose agar diffusion procedures [23]. 
 
Fig. 17: Pyrazoline derivative carrying benzene sulfonamide 
  
Nosrat et al. (2013) prepared novel 2-(3, 5-diphenyl-4, 5-dihydro-
1H-pyrazol-1-yl)-4-phenylthiazoles via cyclo-condensation of 
several chalcones, phenacyl bromide and thiosemicarbazide. The 
reaction was efficiently conducted under reflux through a few drops 
of HCl in Ethanol. The antibacterial action of compounds was 
observed, Certain compounds display satisfactory actions [24]. 
 
 
Fig. 18: Substituted 2-(3, 5-diphenyl-4, 5-dihydro-1H-pyrazol-1-
yl)-4-phenylthiazoles 
 
Rani et al. (2014) synthesized the sequence of new pyrazoline 
derivative as well as antimicrobial activity of certain pyrazoline 
derivatives and the structures were identified by spectral fig. Certain 
derivatives exhibited analogous results after tested against Y. 
enterocolitica, A. hydrophila, S. aureus and L. monocytogene. Some 
derivatives display additional action as compared to the standard 
drugs tetracycline (30 µg) and gentamicin (10 µg) [25].  
 
 
Fig. 19: Tricyclic pyrazoline derivative 
 
Vidya et al. (2014) have reported a modest, well-organized method 
for the synthesis of novel 2-pyrazolines. In this, the chalcones 
condense with hydrazine hydrate/isoniazid/tolylsulfonyl hydrazide 
results pyrazoline derivatives. The synthesized derivatives have 
been tested for antimicrobial activity in several types of micro-
organisms. An important level of activity was noticed [26]. 
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Fig. 20: Novel 2-pyrazolines 
 
Desai et al. (2014) synthesized quinazolinyl-2-pyrazoline derivatives 
series and screened for the in vitro antibacterial potency against 
gram-positive strains (S. Aureus, B. Subtilis) and gram negative 
strains (E. coli, P. aeroginosa) comparing with the standard drugs 
ampicillin, amoxycillin and penicillin and antifungal activity against 
C. Albicans and C. Krusei. as compared with fluconazole by disc 
diffusion method [27].  
 
 
Fig. 21: Quinazolinyl 2-pyrazolines 
Ishwar Bhat et al. (2014) were reported that the reactions of 
chalcones with aryloxy acetyl hydrazines yield (70-80%) 1, 3, 5 
substituted pyrazoline derivatives in the presence of glacial acetic 
acid. Synthesized compounds were screened for antibacterial, 
antifungal and antitubercular activity studies. Synthesized 
compounds showed significant activity against ampicillin and 
moderate to significant antifungal activity against griseofulvin. 
Antibacterial activity studies revels that good antitubercular 
activities against isoniazid as a standard drug [28]. 
 
 
Fig. 22: 1, 3, 5 Substituted pyrazoline derivatives 
 
Viveka et al. (2015) reported substituted pyrazole skeleton linked 
newly synthesis of pyrazolines. The reaction was accomplished by a 
multistep procedure. They were tested these novel derivatives for 
antibacterial, analgesic and anti-inflammatory activities. The 
derivatives which contain halogen atom at phenyl ring on 3rd 
position of the pyrazoline ring were establish to be active in contrast 
to bacteria at the conc. of 0.2–0.4 mg/ml. Derivatives those 
containing N-propionyl pyrazolyl-pyrazoline recognized as, having 
dual activity, anti-inflammatory and antibacterial activity [29]. 
 
   
Fig. 23: Newly synthesis of pyrazolines 
 
Alam et al. (2015) synthesized a series of pyrazoline derivatives and 
structural identification done by 1H NMR, [13]C NMR, IR and Mass 
spectrum. All newly synthesized derivatives were evaluated against 
two bacterial and four fungal strain (C. Albicans, A. Flavus, A. 
Fumigatus, A. versicola) at the conc. of 12.5µg/ml compared with 
standard drug fluconazole. All compounds display moderate to 
potent antifungal activity [30].  
 
 
Fig. 24: Disubstituted pyrazoline derivatives 
Parajuli et al. (2015) reported that the reaction of chalcones with 
phenylhydrazine results a novel 3-phenyl-5-(4-dimethylaminophenyl)-
1-phenyl-pyrazolone. The synthesized compounds were tested against S. 
faecalis, S. aureus and E. coli for their antibacterial activity by disc 
diffusion method. The researcher concluded on the basis of antibacterial 
evaluation data that the synthesized new compounds showed sufficient 
antibacterial activity towards S. aureus [31].  
 
 
Fig. 25: Novel 3-phenyl-5-(4-dimethylaminophenyl)-1-phenyl-
pyrazoline 
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Sulthana et al. (2015) reported a research paper on design and 
synthesis a new series of thiophene and benzodioxole appended 
thiazolyl-pyrazoline derivatives by the microwave-assisted method 
and screened for antimicrobial potency against different bacteria 
and fungi. Few compounds show good antimicrobial potency [32].  
 
 
Fig. 26: Thiazolyl-pyrazoline derivatives 
 
Alnitop et al. (2015) synthesized Thiazolyl-pyrazoline derivatives and 
subjected to evaluate for antifungal potency against the pathogenic 
yeast and mold by broth microdilution method as compared to 
standard drug ketoconazole at the MIC conc. of 250 µg/ml [33]. 
 
 
Fig. 27: Thiazolyl-pyrazoline derivatives 
 
Indorkar et al. (2015) published a research paper on newly 
synthesized 1-acetyl/acetophenyl-3-(4-nitrophenyl)-5-(substituted 
phenyl) pyrazoline derivative. They tested them for antimicrobial 
potency against the pathogenic bacterial strains such as B. subtilis, E. 
coli, K. pneumonia and S. aureus. Further tested against a pathogenic 
panel of fungal strains like A. niger, A. flavus, T. viride and C. albicans 
for antifungal activity. On the basis of obtained results, it is 
concluded that almost all the synthesized new pyrazoline 
derivatives had displayed variable growth inhibitory effects [34]. 
 
 
Fig. 28: 1-acetyl/acetophenyl-3-(4-nitrophenyl)-5-(substituted 
phenyl) pyrazoline derivative 
 
Karangiya et al. (2016) reported a series of newly synthesized 3-
(Aryl)-5-[4-(2,4-Dichlorophenylmethoxy)-3-methoxyphenyl]-4,5-
dihydro pyrazoline and 3-(Aryl)-5-[4-(2,4-Dichlorophenylmethoxy)-3-
methoxyphenyl]-4,5-dihydroacetyl pyrazoline derivatives. The 
chalcones were synthesized by Claisen-Schmidt condensation. The 






Ahmed et al. (2016) reported the synthesis of two series of 
pyrazoline derivatives beginning from p-acetamidophenol 
(paracetamol) and screened for antimicrobial activity. Chalcones 
were prepared by reacting 3-acetyl-4-hydroxyphenyl acetamide 
with different aromatic aldehydes. These chalcones were further 
reacted with phenylhydrazine and isoniazid to get phenyl-
pyrazolines and isoniazid-pyrazolines. New pyrazoline derivatives 
displayed important antibacterial potency against E. coli, S. aureus, 
and P. aeruginosaas compared using the standard antibiotic 
ciprofloxacin. In the conclusion found that some derivatives 
possesses powerful antibacterial activity against S. aureus, P. 




Fig. 30: (a) phenyl-pyrazolines and (b) isoniazid-pyrazolines 
 
Muneera et al. (2016) synthesized biologically active pyrazoline 
derivatives by the reaction of imidazole-2-carboxaldehyde with 1-
acetyl-2-hydroxynaphthalene using Claisen–Schmidt condensation 
reaction. Metal acetates ligands further formed from the metal 
complexes with Ni(II), Co(II), Cu(II) and Zn(II) metals, respectively. 
All metal complexes structures were analytically confirmed by IR, 
NMR, Mass, ESR spectroscopy and elemental analysis. All 
synthesized derivatives were screened against bacterial strains E. 
coli, S. aureus, K. pneumoniae, Proteus mirabilis and S. typhii as 
compared to the standard drug streptomycin. All compounds also 
were estimated for in vitro antimycobacterial activity against 
Mycobacterium tuberculosis [37].  
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Fig. 31: Metal complex of pyrazoline derivatives 
 
Sid et al. (2016) synthesized the 1-formyl-3-phenyl-5-(4-
isopropylphenyl)-2-pyrazoline as pure crystal and their structure 
was confirmed by spectral analysis like FT-IR, NMR, XRD. Compound 
was screened for anti-microbial activity and the compound shows 
favorable activity [38]. 
 
 
Fig. 32: 1-formyl-3-phenyl-5-(4-isopropylphenyl)-2-pyrazoline 
 
Patel et al. (2016) reported the synthesis of 2-pyrazolines from 
chalcones by conventional and microwave-assisted techniques. All 
new compounds have been confirmed by The 1HNMR,[13]C NMR, IR 
and Mass spectroscopy. All the synthesized compounds were 
screened for antibacterial potency against gram-positive bacteira (S. 
Aureus, S. Pyrogens) at the conc. of 200 µg/ml, and gram-negative 
bacteria (P. Aeruginosa, E. coli) at the conc. of 500 µg/ml as 
compared to standard ampicillin and for the antifungal potency 
against A. niger, C. Albicans, A. Clavatus at conc. of 250,500, 1000 
µg/ml as compared with the standard griseofulvin and nystatin [39]. 
 
 
Fig. 33: 2-pyrazolines derivatives 
 
Shamsuzzaman et al. (2016) synthesized a new steroidal pyrazoline 
derivatives series by the reaction between α, β unsaturated ketone 
in DMSO and 2,4 dinitrophenyl hydrazine with few drops of acetic 
acid. The structures of synthesized new derivatives were elucidated 
by 1HNMR, [13]C NMR, IR, Mass spectra and analytical data. The 
synthesized compound were evaluated for antimicrobial potency 
against Coryne bacterium xerosis, S. epidermidis, E. coli by disc 
diffusion method as compared to the gentamicin and anti fungal 
activity against M. azygosporus, A. niger C. purpurea, as compared 
with the standard drug ketoconazole [40]. 
 
Fig. 34: New steroidal pyrazoline derivatives 
Karad et al. (2016) synthesized a novel morpholino quinoline based 
conjugates with pyrazoline moiety by microwave irradiation 
technique. The new compounds were evaluated for in vitro 
antibacterial activity against pathogenic strains of bacteria and fungi 
comparing with standard drugs ampicillin, chloramphenicol, 
ciprofloxacin and griseofulvin [41]. 
 
 
Fig. 35: Morpholino quinoline based pyrazoline 
 
Tejas J. Shah et al. (2016) prepared a series of 3-[3’-(2”,4”-dichloro-5”-
fluorophenyl)-5’-(2”-furyl)-4’, 5’-dihydro-1H-pyrazol-1’-yl]-5-
substituted phenyl-2-pyrazolines and 1-Nitroso-3-[3’-(2”,4”-dichloro-5”-
fluorophenyl)-5’-(2”-furyl)-4’,5’-dihydro-1H-pyrazol-1’-yl]-5-substituted 
phenyl-2-pyrazolines. Some compounds exhibited antimicrobial activity 
against some Gram (+) and Gram (–) bacteria [42].  
Desai et al. (2017) synthesized few novel derivatives of (5-(2-
chloroquine in-3-yl)-3-(aryl)-4, 5-dihydro-1H-pyrazol-1-yl)(pyridin-
4-yl) methanones moieties embedded in different biologically active 
heterocyclic compounds e. g. pyrazoline quinoline and pyridine 
derivatives. Reported compounds were analytically determined by 
spectrometric methods like IR, 1H NMR, [13]C NMR, Mass spectra. 
These compounds were screened for antimicrobial activity on four 
strains of bacteria (S. aureus, S. pyogenes, E. coli, P. aeruginosa) and 
three strains of fungi (C. albicans, A. niger, A. clavatus) using 






Mishra et al. (2017) prepared a novel series of 1, 3, 5-trisubstituted 
pyrazoline derivatives by reacting chalcones and nicotinic acid 
hydrazide in two steps. 1st step is the preparation of chalcones by 
treatment of substituted benzaldehyde with 4-hydroxy 
acetophenone by Claisen-Schimidt Condensation. 2nd step is the 
reflux condensation of isoniazid with chalcones in alkaline ethanol 
results in various pyrazoline derivatives. The newly manufactured 
compounds were structurally confirmed by spectral analysis (IR, 1H 
NMR,[13]C NMR) and elemental analysis. The pyrazoline derivatives 
were screened for antibacterial and antimalarial activity as 
compared to the standard drugs ciprofloxacin. The compounds were 
tested on bacteria S. aureus, B. Subtilis, E. coli and P. aeruginosa, and 
fungus against A. niger at the MIC-3.25 μg/ml and C. albicans at MIC-
6.5 μg/ml as compared with the standard drug fluconazole. For 
antimalarial activity, the pyrazoline derivatives were tested against 
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chloroquine-sensitive and chloroquine-resistant P. falciparum 
strains [44].  
 
Fig. 37: Novel series of 1, 3, 5-trisubstituted pyrazolines 
 
Rashmi et al. (2017) synthesized a novel series of four 1-
thiocarbamoyl-3, 5-diphenyl-2-pyrazoline derivatives by microwave 
irradiation method in a modified domestic microwave oven. The 
synthesized new compounds were evaluated for their antibacterial 
activity by well diffusion method against two gram-positive strains 
(Staphylococcus aureus MRSA, Pseudomonas spp.) and two gram-
negative strains (Escherichia coli, Bacillus cereus). The synthesized 
compounds 1-thiocarbamoyl-3,5-diphenyl-2-pyrazoline and 1-
thiocarbamoyl-3-(4’-chlorophenyl)-5-(4-chlorophenyl)-2-pyrazoline 
showed potent activity against both the gram-positive strains 
Staphylococcus aureus MRSA and Pseudomonas spp [45]. 
 
 
Fig. 38: 1-thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives 
 
Sadashiva et al. (2017) published a research paper on the design and 
synthesis of 2, 4 disubstituted 1,3-thiazoles linked pyrazoline moiety 
series. The structural elucidation of synthesized new compounds was 
done by UV-Vis, IR, NMR, Mass spectroscopy and elemental analysis. 
The new compounds were screened for in vitro, antimicrobial activity 
against some pathogenic microbial strains [46]. 
 
 
Fig. 39: 2, 4 disubstituted 1,3-thiazoles linked pyrazolines 
 
R Umadevi (2017) synthesized some novel pyrazoline derivatives 
from chalcones which are prepared by the treating 2-acetyl-5-
bromothiophene with various aromatic aldehydes. These chalcones 
further condensate with phenylhydrazine HCL, pyridine as a catalyst 
results 3-(5-bromo thiophene-2-yl)1-phenyl-1-pyrazole derivatives. 
The synthesized compounds have been identified by their melting 
point, TLC, IR and NMR spectral data. All the synthesized compounds 
have been evaluated for antibacterial potential against gram-positive 
bacterial strains, B. subtillis and B. pumilus and gram-negative bacterial 
strains E. coli and P. vulgaris and antifungal activity against fungal 
strains, A. niger and p. crysogenium [47]. 
 
Fig. 40: 3-(5-bromo thiophene-2-yl)1-phenyl-1-pyrazole 
derivatives 
 
Kumarswami et al. (2017) synthesized some new pyrazoline 
derivatives from chalcones and the hydrazine hydrate in alkaline 
ethanol. The chalcones have been prepared by the reaction of 
acetophenone with various benzaldehyde. The synthesized new 
compounds were characterized by NMR, IR and mass spectroscopy. 
All the compounds were evaluated for antibacterial activity against 
gram-positive strains (S. Aureus, B. Subtilis) and gram negative 
strains (E. coli, K. Pneuminoae) at suitable conc. as compared to 
standard drug ciprofloxacin. All the compounds showed moderate to 
potent antibacterial activity [48]. 
 
 
Fig. 41: New pyrazoline derivatives 
 
Yusuf et al. (2017) synthesized a series of bispyrazolines from the 
cyclization of bischalcone with phenylhydrazine by reflux in dry 
acidic ethanol medium. According to Claisen–Schmidt condensation 
reaction, chalcone obtained by reacting p-hydroxy acetophenone 
with 2-furfuraldehyde. The bischalcones and bispyrazolines 
structures were confirmed by 1H NMR, 13C NMR, IR and Mass 
spectroscopy. Newly synthesized compounds were screened for 
their antimicrobial potency against seven strains of bacteria (E. coli,, 
K. pneumonia, P. fluorescens, S. aureus, P. aeruginosa B. subtilis, S. 
pyrogen,) and five strains of fungus (A. sclerotium, Penicillium 
glabrum, A. niger, A. janus, Fusarium oxysporum) by using serial tube 




Fig. 42: Bispyrazolines 
 
Burmidza et al. (2018) synthesized a series of ferrocenyl ketones by 
the reaction of ferrocene with substituted acryloyl chlorides. The 
reaction of ferrocenyl ketones with hydrazine in acidic medium 
prepares new pyrazoline derivatives. 12 strains of microbes 
Jain et al. 
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(bacteria and fungi) were taken for antimicrobial activities of 
synthesized compounds as compared to standard drugs 
streptomycin and ketoconazole at the MIC conc. from 0.039-
0.312 mg/ml [50]. 
Siliveri et al. (2019) reported the design and synthesis of pyrazoline 
incorporated 1,2,3 triazole benzene sulphonamides and all the 
synthesized compounds were characterized by FT IR, HNMR, 
13CNMR and Mass spectra. The synthesized compounds were 
evaluated for cytotoxic activity through using 3-(4, 5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
and anti-gout activity by potassium oxonate induced assay [51]. 
Asad et al. (2020) synthesized a series of N-propionyl 2-pyrazolines 
from the chalcones by reacting propionic acid with hydrazine 
hydrate. The atomic structure of new pyrazoline derivatives were 
confirmed by FT-IR, NMR spectroscopy, crystal structure, X-ray 
diffraction techniques. All new compounds were evaluated for 
antibacterial activity against gram-positive bacterial strain (B. 
Subtilis, S. Aureus) and gram-negative bacterial strain (E. Coli, P. Peli). 
All new compounds display significant activity against bacteria [52].  
 
 
Fig. 43: N-propionyl 2-pyrazolines 
 
CONCLUSION 
The objective of this review is to provide a platform for 
researcher, academician, chemist and industrialists to have all the 
information regarding the antimicrobial activity of pyrazoline. 
Various synthetic routes were discussed with its chemistry. The 
literature eliciting the antimicrobial activity were discussed. As 
the literature shows that there is always demand of novel 
antimicrobial agents due to the pathogen resistance. So, this 
literature would be fruitful to the society as well. This would 
provide the researcher a lead that they may come with a new and 
potent pyrazoline bearing derivative. 
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